| ASSET | QUARTER | % RETURN |
|---|---|---|
Future Fintech (FTFT) | Q3 2007 | 232,581.49% |
Archrock (AROC) | Q3 2007 | 152,372.44% |
Travere Therapeutics (TVTX) | Q3 2007 | 600% |
QXO (QXO) | Q3 2007 | 333.33% |
Biocardia (BCDA) | Q3 2007 | 300% |
Alnylam Pharmaceuticals (ALNY) | Q3 2007 | 114.32% |
Sanara Medtech (SMTI) | Q3 2007 | 113.33% |
Riot Platforms (RIOT) | Q3 2007 | 109.78% |
Capricor Therapeutics (CAPR) | Q3 2007 | 109.76% |
AI Financial (AIFC) | Q3 2007 | 103.1% |
Lexaria Bioscience (LEXX) | Q3 2007 | 102.86% |
Repro Med Systems (KRMD) | Q3 2007 | 100% |
CBAK Energy Technology (CBAT) | Q3 2007 | 95.97% |
Biomerica (BMRA) | Q3 2007 | 92.5% |
Arts-Way Manufacturing (ARTW) | Q3 2007 | 90.52% |
Taoping (TAOP) | Q3 2007 | 85.57% |
Corcept Therapeutics (CORT) | Q3 2007 | 78.83% |
Galectin Therapeutics (GALT) | Q3 2007 | 76.32% |
Wynn Resorts (WYNN) | Q3 2007 | 74.58% |
Las Vegas Sands (LVS) | Q3 2007 | 71.45% |
China Natural Resources (CHNR) | Q3 2007 | 69% |
Lululemon Athletica (LULU) | Q3 2007 | 68.12% |
Baidu (BIDU) | Q3 2007 | 67.48% |
NetSol Technologies (NTWK) | Q3 2007 | 66.48% |
Intuitive Surgical (ISRG) | Q3 2007 | 65.47% |